Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies

被引:109
作者
Ganesh, L
Leung, K
Loré, K
Levin, R
Panet, A
Schwartz, O
Koup, RA
Nabel, GJ
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Biol Imaging Facil, NIH, Bethesda, MD 20892 USA
[3] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel
[4] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Virol, IL-91010 Jerusalem, Israel
关键词
D O I
10.1128/JVI.78.21.11980-11987.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The tropism of human immunodeficiency virus type I for chemokine receptors plays an important role in the transmission of AIDS. Although CXCR4-tropic virus is more cytopathic for T cells, CCR5-tropic strains are transmitted more frequently in humans for reasons that are not understood. Phenotypically immature myeloid dendritic cells (mDCs) are preferentially infected by CCR5-tropic virus, in contrast to mature mDCs, which are not susceptible to infection but instead internalize virus into a protected intracellular compartment and enhance the infection of T cells. Here, we define a mechanism to explain preferential transmission of CCR5-tropic viruses based on their interaction with mDCs and sensitivity to neutralizing antibodies. Infected immature mDCs differentiated normally and were found to enhance CCR5-tropic but not CXCR4-tropic virus infection of T cells even in the continuous presence of neutralizing antibodies. Infectious synapses also formed normally in the presence of such antibodies. Infection of immature mDCs by CCR5-tropic virus can therefore establish a pool of infected cells that can efficiently transfer virus at the same time that they protect virus from antibody neutralization. This property of DCs may enhance infection, contribute to immune evasion, and could provide a selective advantage for CCR5-tropic virus transmission.
引用
收藏
页码:11980 / 11987
页数:8
相关论文
共 51 条
[11]   NEUTRALIZATION OF DIVERGENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS AND PRIMARY ISOLATES BY IAM-41-2F5, AN ANTI-GP41 HUMAN MONOCLONAL-ANTIBODY [J].
CONLEY, AJ ;
KESSLER, JA ;
BOOTS, LJ ;
TUNG, JS ;
ARNOLD, BA ;
KELLER, PM ;
SHAW, AR ;
EMINI, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3348-3352
[12]   SEQUENCE AND EXPRESSION OF A MEMBRANE-ASSOCIATED C-TYPE LECTIN THAT EXHIBITS CD4-INDEPENDENT BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN-GP120 [J].
CURTIS, BM ;
SCHARNOWSKE, S ;
WATSON, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8356-8360
[13]   Loss of blood CD11c+ myeloid and CD11c- plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load [J].
Donaghy, H ;
Pozniak, A ;
Gazzard, B ;
Qazi, N ;
Gilmour, J ;
Gotch, F ;
Patterson, S .
BLOOD, 2001, 98 (08) :2574-2576
[14]   Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1 [J].
Donaghy, H ;
Gazzard, B ;
Gotch, F ;
Patterson, S .
BLOOD, 2003, 101 (11) :4505-4511
[15]   Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials [J].
DSouza, MP ;
Livnat, D ;
Bradac, JA ;
Bridges, SH ;
Bryson, Y ;
Hanson, C ;
Matthews, T ;
Moore, J ;
Trkola, A ;
ZollaPazner, S ;
Gorny, M ;
Burton, D ;
Merigan, T ;
McNamara, J ;
Norcross, M ;
Posner, M ;
Robinson, J ;
ViraniKetter, N ;
Barbas, CF ;
Parren, P ;
Katinger, H .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1056-1062
[16]   Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes [J].
Engering, A ;
van Vliet, SJ ;
Geijtenbeek, TBH ;
van Kooyk, Y .
BLOOD, 2002, 100 (05) :1780-1786
[17]   HIV-1 infection of placental cord blood monocyte-derived dendritic cells [J].
Folcik, RM ;
Merrill, JD ;
Li, Y ;
Guo, CJ ;
Douglas, SD ;
Starr, SE ;
Ho, WZ .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (05) :609-620
[18]   Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells [J].
Frankel, SS ;
Steinman, RM ;
Michael, NL ;
Kim, SR ;
Bhardwaj, N ;
Pope, M ;
Louder, MK ;
Ehrenberg, PK ;
Parren, PWHI ;
Burton, DR ;
Katinger, H ;
VanCott, TC ;
Robb, ML ;
Birx, DL ;
Mascola, JR .
JOURNAL OF VIROLOGY, 1998, 72 (12) :9788-9794
[19]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[20]   Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-Tropic virus to T cells [J].
Granelli-Piperno, A ;
Delgado, E ;
Finkel, V ;
Paxton, W ;
Steinman, RM .
JOURNAL OF VIROLOGY, 1998, 72 (04) :2733-2737